by Ian Le Guillou, Department of Biochemistry, University of Cambridge Although contradictory to the hopes of the Access to Understanding competition, writing about the work described in ‘NLK is a Novel Therapeutic Target for PTEN Deficient Tumour Cells‘ made me realise the importance of scientific jargon. Yes, it makes research very difficult to understand for anyone outside of that specialism, but it exists for a reason.